About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.80 (-3.97%)
CNTB NASDAQ Connect Biopharma Holdings Ltd
Loading watchlist status…
Connect Biopharma Holdings Ltd share price
CNTB price activity
Last Price
$0.800
Change (24hr)
-0.03 USD (3.97%)
Volume
2.50M
Volume (4w avg)
-
Open
$0.83
Day Range
$0.78 - $0.87
Previous Close
$0.84
Last Trade
30 Oct, 8:00 pm GMT+0
Delayed
30 Oct, 8:00 pm GMT+0
CNTB price performance
-4.78%
5D
-18.12%
1M
-71.55%
YTD
-53.09%
1Y
Delayed
30 Oct, 8:00 pm GMT+0
CNTB Market Signals